Results 171 to 180 of about 32,249 (192)

Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine–naïve adults 60–64 years of age

Vaccine, 2014
Kathrin U Jansen, Robert Frenck, Daniel Scott   +2 more
exaly  

Pneumococcal polysaccharide vaccines

The Indian Journal of Pediatrics, 1982
openaire   +2 more sources

Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older

Vaccine, 2013
Robert Frenck, Daniel Scott, William Gruber   +2 more
exaly  

Pneumococcal vaccine and the elderly

The Lancet, 2000
openaire   +2 more sources

Indirect cohort analysis of 10-valent pneumococcal conjugate vaccine effectiveness against vaccine-type and vaccine-related invasive pneumococcal disease

Vaccine, 2015
Jennifer Verani, JOSÉ Moraes, Carla Magda Allan Santos Domingues   +2 more
exaly  

Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide–protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

Vaccine, 2007
David Shay, Moon Nahm, James Baggs
exaly  

Multivalent pneumococcal vaccines

2023
BESIN GILLES R, BROERING TERESA J, BURKE HEIDI, LU YINGJIE, MALLEY RICHARD, MCCOMBS JANET E, PUVANESARAJAH VELUPILLAI, SEBASTIAN SHITE, SHARMA ONKAR, STEVENSON TAYLOR C, YAO GANG, ZHANG FAN   +11 more
openaire   +3 more sources

Effectiveness of pneumococcal vaccine

The Lancet, 1998
M C, Steinhoff, L, Moulton, J, Clemens
openaire   +2 more sources

Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people

Lancet, The, 1998
Maija Leinonen, Jonas Hedlund, Åke Ortqvist   +2 more
exaly  

Public health impact of pneumococcal conjugate vaccine infant immunization programs: assessment of invasive pneumococcal disease burden and serotype distribution

Expert Review of Vaccines, 2018
Christopher Clarke, Patricia Izurieta, Richard Adegbola   +2 more
exaly